As the European Central Bank’s recent rate cuts have bolstered expectations for further monetary easing, the pan-European STOXX Europe 600 Index has seen a modest rise, reflecting a cautiously optimistic market sentiment. In this environment, identifying high-growth tech stocks in Sweden involves looking for companies that can capitalize on innovation and adaptability to thrive amid evolving economic conditions.
Name
Revenue Growth
Earnings Growth
Growth Rating
Truecaller
20.45%
21.76%
★★★★★★
Xbrane Biopharma
53.90%
118.02%
★★★★★★
Hemnet Group
20.11%
25.40%
★★★★★★
Scandion Oncology
40.71%
75.34%
★★★★★★
BioArctic
42.38%
98.40%
★★★★★★
Biovica International
81.67%
78.55%
★★★★★★
Yubico
20.52%
42.18%
★★★★★★
Bonesupport Holding
33.76%
31.20%
★★★★★★
KebNi
34.75%
86.11%
★★★★★★
Skolon
32.63%
122.14%
★★★★★★
Click here to see the full list of 82 stocks from our Swedish High Growth Tech and AI Stocks screener.
Let’s uncover some gems from our specialized screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: BioGaia AB (publ) is a healthcare company that offers probiotic products globally, with a market capitalization of SEK9.91 billion.
Operations: The company focuses on the global distribution of probiotic products, generating revenue primarily from these offerings.
Despite a challenging year with a 23% dip in earnings, BioGaia’s strategic focus on R&D spending and innovation remains robust, underpinning its recovery potential. With an expected annual revenue growth of 14.7%, outpacing the Swedish market average of 0.9%, and earnings projected to surge by 21.2% annually, the company is positioning itself strongly against market norms. Recent financials reveal a downturn with Q3 net income dropping to SEK 36.6 million from SEK 101.5 million year-over-year; however, BioGaia’s consistent investment in research (specific figures not provided) could foster significant advancements in biotech, potentially revitalizing its market stance and investor confidence.
OM:BIOG B Revenue and Expenses Breakdown as at Oct 2024
Simply Wall St Growth Rating: ★★★★★☆
Overview: Lime Technologies AB (publ) offers SaaS-based CRM solutions primarily in the Nordic region, with a market capitalization of SEK4.53 billion.
Operations: The company generates revenue through selling and implementing CRM software systems, totaling SEK631.84 million.
Lime Technologies, navigating a competitive tech landscape in Sweden, has demonstrated robust financial health with a 22.4% forecasted annual earnings growth and an impressive 14.2% expected revenue increase per year, outpacing the broader Swedish market’s average of 0.9%. Notably, the company’s commitment to innovation is evident from its R&D spending trends which are strategically aligned with its growth trajectory—ensuring sustainability in its software solutions development. Despite facing challenges such as high debt levels, Lime’s recent earnings call highlighted strategic initiatives aimed at leveraging their strong market position to enhance shareholder value through focused investments and potential market expansions.
Story Continues
Simply Wall St Growth Rating: ★★★★☆☆
Overview: NCAB Group AB (publ) is a company that manufactures and sells printed circuit boards (PCBs) across Sweden, the Nordic region, Europe, North America, and Asia with a market capitalization of approximately SEK12.23 billion.
Operations: The company generates revenue primarily from its operations in Europe, the Nordic region, North America, and East Asia. Europe is the largest contributor with SEK2.02 billion, followed by the Nordic region and North America at SEK777 million and SEK767 million respectively.
NCAB Group, navigating Sweden’s tech sector, has shown resilience despite a challenging economic backdrop. With expected revenue growth at 9.3% annually, outpacing the Swedish market average of 0.9%, NCAB is adapting to slower market conditions as evidenced by its recent guidance predicting a downturn in Q3 sales year-over-year. The company’s commitment to innovation is underscored by its R&D spending, crucial in maintaining competitive edge amidst softening demand in key European markets. Despite these hurdles, NCAB’s earnings are set to grow by 16.6% per year, suggesting robust internal efficiencies and a strategic focus that could stabilize its financial trajectory in uncertain times.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include OM:BIOG B OM:LIME and OM:NCAB.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=67185d358ce848c4b9990ae6074949d1&url=https%3A%2F%2Ffinance.yahoo.com%2Fnews%2Fhigh-growth-tech-stocks-sweden-020631785.html&c=2398989161332786377&mkt=de-de
Author :
Publish date : 2024-10-22 19:18:00
Copyright for syndicated content belongs to the linked Source.